RB1 and breast cancer: The importance of loss of PP2A activity for CML disease progression is also supported by the ability of PP2A to induce Rb dephosphorylation (Avni et al, 2003) and suppress Jak2 kinase, which was found activated in CML-BC (Xie et al, 2002).